| 6th Mar 2024 3:05 pm |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2024 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2024 7:00 am |
RNS |
EMA validates Dato-DXd MAAs for NSQ NSCLC and BC |
| 1st Mar 2024 3:00 pm |
RNS |
Total Voting Rights |
| 26th Feb 2024 7:00 am |
RNS |
Voydeya recommended for EU approval |
| 22nd Feb 2024 1:15 pm |
RNS |
Acquisition of Gracell completed |
| 22nd Feb 2024 11:00 am |
RNS |
Director/PDMR Shareholding |
| 22nd Feb 2024 7:00 am |
RNS |
AstraZeneca prices a $5bn bond offering |
| 21st Feb 2024 7:00 am |
RNS |
Filing of Form 20-F with SEC |
| 20th Feb 2024 11:00 am |
RNS |
Annual Financial Report |
| 19th Feb 2024 3:00 pm |
RNS |
AstraZeneca completes acquisition of Icosavax |
| 19th Feb 2024 7:10 am |
RNS |
Tagrisso plus chemo approved in US for lung cancer |
| 19th Feb 2024 7:05 am |
RNS |
FDA accepts Dato-DXd BLA for nonsquamous NSCLC |
| 19th Feb 2024 7:00 am |
RNS |
Tagrisso improved PFS in Stage III lung cancer |
| 8th Feb 2024 7:00 am |
RNS |
Final Results |
| 1st Feb 2024 3:00 pm |
RNS |
Total Voting Rights |
| 2nd Jan 2024 3:00 pm |
RNS |
Total Voting Rights |
| 27th Dec 2023 7:00 am |
RNS |
AstraZeneca acquires Gracell |
| 22nd Dec 2023 7:00 am |
RNS |
Wainua (eplontersen) granted first US FDA approval |
| 14th Dec 2023 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 12th Dec 2023 7:05 am |
RNS |
AstraZeneca to acquire Icosavax |
| 1st Dec 2023 3:05 pm |
RNS |
Block listing Interim Review |
| 1st Dec 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Dec 2023 7:00 am |
RNS |
Discontinuation of two CRYSTALIZE evidence trials |
| 23rd Nov 2023 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 17th Nov 2023 7:00 am |
RNS |
Truqap approved in US for HR+ breast cancer |
| 14th Nov 2023 7:05 am |
RNS |
Update on PACIFIC-2 Phase III trial for Imfinzi |
| 9th Nov 2023 3:00 pm |
RNS |
Director Declaration |
| 9th Nov 2023 7:10 am |
RNS |
Imfinzi combination improves PFS in liver cancer |
| 9th Nov 2023 7:05 am |
RNS |
Agreement with Eccogene for clinical stage GLP-1RA |
| 9th Nov 2023 7:00 am |
RNS |
9M and Q3 2023 results |
| 1st Nov 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Nov 2023 7:00 am |
RNS |
AstraZeneca cell & gene therapy deal w/ Cellectis |
| 3rd Oct 2023 7:00 am |
RNS |
AstraZeneca settles Nexium liability litigations |
| 2nd Oct 2023 3:00 pm |
RNS |
Total Voting Rights |
| 22nd Sep 2023 7:00 am |
RNS |
Dato-DXd improved PFS in breast cancer |
| 20th Sep 2023 7:00 am |
RNS |
Alexion completes Pfizer gene therapy agreement |
| 15th Sep 2023 3:00 pm |
RNS |
Enhertu recommended in EU for HER2-mutant NSCLC |
| 11th Sep 2023 4:00 pm |
RNS |
Fasenra Phase III EGPA trial met primary endpoint |
| 6th Sep 2023 7:00 am |
RNS |
Update on US review of Ultomiris for NMOSD |
